- Home
- DAWN vs WB Comparison
DAWN vs WB Comparison
Compare DAWN & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- WB
- Stock Information
- Founded
- DAWN 2018
- WB 2009
- Country
- DAWN United States
- WB China
- Employees
- DAWN N/A
- WB N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- WB Computer Software: Programming Data Processing
- Sector
- DAWN Health Care
- WB Technology
- Exchange
- DAWN Nasdaq
- WB Nasdaq
- Market Cap
- DAWN 624.8M
- WB 2.8B
- IPO Year
- DAWN 2021
- WB 2014
- Fundamental
- Price
- DAWN $7.23
- WB $12.42
- Analyst Decision
- DAWN Strong Buy
- WB Buy
- Analyst Count
- DAWN 7
- WB 2
- Target Price
- DAWN $27.86
- WB $14.00
- AVG Volume (30 Days)
- DAWN 999.9K
- WB 1.3M
- Earning Date
- DAWN 10-29-2025
- WB 08-14-2025
- Dividend Yield
- DAWN N/A
- WB 12.96%
- EPS Growth
- DAWN N/A
- WB 9.65
- EPS
- DAWN N/A
- WB 1.41
- Revenue
- DAWN $187,638,000.00
- WB $1,762,960,000.00
- Revenue This Year
- DAWN $12.56
- WB $1.39
- Revenue Next Year
- DAWN $48.02
- WB $2.14
- P/E Ratio
- DAWN N/A
- WB $8.66
- Revenue Growth
- DAWN 2190.50
- WB 1.37
- 52 Week Low
- DAWN $5.64
- WB $7.10
- 52 Week High
- DAWN $16.76
- WB $12.91
- Technical
- Relative Strength Index (RSI)
- DAWN 51.86
- WB 62.80
- Support Level
- DAWN N/A
- WB $11.89
- Resistance Level
- DAWN $7.58
- WB $12.92
- Average True Range (ATR)
- DAWN 0.24
- WB 0.38
- MACD
- DAWN -0.31
- WB 0.05
- Stochastic Oscillator
- DAWN 93.04
- WB 74.14
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About WB Weibo Corporation
Weibo Corp is a China-based company mainly engaged in the social media advertising business for people to create, discover and distribute content. The company's activities include Advertising and Marketing, which mainly provides a full range of advertising customization and marketing solutions. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The Company's main product is the social platform Weibo.